Physician profile
Mark W Cloud
NPI 1205863735
$1,650.76
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $983 · 2020: $466 · 2021: $146 · 2022: $27.88 · 2023: $13.26 · 2024: $14.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $27.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $27.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $299.96 | 2019-2021 | |
| Astellas Pharma US INC | $240.99 | 2019-2020 | |
| Pfizer INC. | $236.15 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.59 | 2019-2021 | |
| Novo Nordisk INC | $143.21 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $110.13 | 2019 | |
| Abbott Laboratories | $80.73 | 2019-2023 | Freestyle Libre 3 |
| Amgen INC. | $71.54 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $70.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.68 | 2020 | |
| Allergan, INC. | $51.78 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $46.52 | 2019-2021 | |
| Medtronic Vascular, INC. | $15.06 | 2020 | |
| Sanofi-Aventis U.S. LLC | $14.81 | 2020 | |
| Boston Scientific Corporation | $14.29 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $13.57 | 2019 | |
| Zyla Life Sciences, INC. | $12.51 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.94 | 2021 | |
| Dynavax Technologies Corporation | $9.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Cloud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.